Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-24-035497
Filing Date
2024-11-15
Accepted
2024-11-15 16:32:09
Documents
14
Period of Report
2024-09-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A wint20241113_8ka.htm   iXBRL 8-K/A 30484
  Complete submission text file 0001437749-24-035497.txt   168313

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA wint-20240925.xsd EX-101.SCH 3410
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20240925_def.xml EX-101.DEF 11793
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20240925_lab.xml EX-101.LAB 15822
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20240925_pre.xml EX-101.PRE 12008
16 EXTRACTED XBRL INSTANCE DOCUMENT wint20241113_8ka_htm.xml XML 2989
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39290 | Film No.: 241468349
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)